You are here

TGA Internet site archive

The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.

Guidelines for levels and kinds of evidence to support indications and claims

Related information

  • Evidence guidelines:
    Guidelines on the evidence required to support indications for listed complementary medicines

V1.1, April 2011

These guidelines have been developed to assist sponsors in determining the appropriate evidence to support indications and claims made in relation to Listable medicines. In particular, they relate to complementary medicines, sunscreens and other Listable medicines.

The Therapeutic Goods Act 1989 requires that at the time of Listing, sponsors must certify that they hold information or evidence to support any claim that the applicant makes relating to the medicine. All indications and claims made about therapeutic goods must be capable of substantiation - that is, evidence must be held by sponsors which demonstrates the indications and claims are true, valid and not misleading.

Sponsors should also make reference to the Australian Regulatory Guidelines for Complementary Medicines (ARGCM) which contain further advice in relation to the evidence requirements to support the indications and claims for Listable medicines. Specifically, ARGCM Part II - Listed Complementary Medicines, Section 6.2.2.

In addition, ARGCM Part I - Registration of Complementary Medicines, Sections 4.1.3 and 7.3 includes the following advice for sponsors in relation to the Registration of complementary medicines:

The Guidelines on levels and kinds of evidence to support claims on therapeutic goods offers advice on the level (general, medium and high) of an indication or claim and the evidence required to support it. Registered medicines can carry claims of any level, provided the TGA has evaluated the evidence to support the indication(s) and approved the indication(s) for the Registered medicine.

How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.


  • Executive summary
    • How to make indications/claims based on evidence of traditional use
    • How to make indications/claims based on scientific evidence
  • Introduction
    • The therapeutic goods regulatory system
  • Levels and kinds of evidence to support claims
    • The kinds of evidence which may support claims
    • What kinds of indications and claims does the evidence support?
  • Registrable diseases list
  • In conclusion
  • Attachment 1: Glossary of terms used in these guidelines
  • Attachment 2: TGA-approved texts
  • Attachment 3: Definitions - types of claims